Prevalence of macrolide resistance in <i>Mycoplasma pneumoniae</i> in The Netherlands
The low resistance rate of 3% still supports the use of macrolides for empirical treatment of M. pneumoniae infections in The Netherlands, but macrolide non-responsive infections should lead to the suspicion of resistant M. pneumoniae. Regular surveillance studies are important as clonal spread may cause rapid changes in resistance rates.
Authors
- Edou R. Heddema (ORCID: https://orcid.org/0000-0001-5199-4226)
- Cas J. A. Peters
- Wil C. van der Zwet (ORCID: https://orcid.org/0000-0003-3625-2229)
- Patrick D J Sturm
- Pieter P A Lestrade
- Julius M Van Niekerk
Institutions
- Maastricht University Medical Centre (NL)
- VieCuri Medisch Centrum (NL)
- Zuyderland Medisch Centrum (NL)
- Laurentius Ziekenhuis (NL)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1093/jac/dkaf475
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00